Clinical Trials · NCT03881995
Effects of Insulin Glargine and Lixisenatide on the Brain
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- University Hospital Tuebingen
- Enrollment
- 1
- Start date
- Mar 2019
- Locations
- 1 site, Germany
- Primary endpoint
- Brain insulin sensitivity